Author | Oliver Sartor, MD | OncLive

Author | Oliver Sartor, MD

Articles

Dr. Sartor on Conclusions and Future of Sipuleucel-T in Prostate Cancer

August 28, 2017

Video

Oliver Sartor, MD, medical oncologist at Tulane University School of Medicine, discusses conclusions drawn from an analysis of African-American patients receiving sipuleucel-T (Provenge) in metastatic castration-resistant prostate cancer and the potential for combinations with this agent.

Dr. Sartor on the Science of Sipuleucel-T for Prostate Cancer

August 18, 2017

Video

Oliver Sartor, MD, a medical oncologist at the Tulane University School of Medicine, discusses the science behind the results of a study investigating sipuleucel-T (Provenge) for patients with castration-resistant prostate cancer (CRPC).

Dr. Sartor on the Next Steps with Sipuleucel-T for Prostate Cancer

August 10, 2017

Video

Oliver Sartor, MD, a medical oncologist at the Tulane University School of Medicine, discusses the next steps with sipuleucel-T (Provenge) for patients with prostate cancer.

Dr. Sartor on Remaining Questions With Sipuleucel-T in mCRPC

July 21, 2017

Video

Oliver Sartor, MD, a medical oncologist at the Tulane University School of Medicine, discusses the remaining questions with sipuleucel-T (Provenge) in metastatic castration-resistant prostate cancer.

x